Planned Phase 2 Trial to Test Vaccine in Triple-negative Breast Cancer Patients, Generex Says
News
Generex Biotechnology has entered into an agreement with the NSABP Foundation to manage a possible Phase 2 clinical trial testing an anti-cancer vaccine in patients with metastatic triple negative breast cancer. ... Read more